Global Soft-Contact Blood Lancet Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Soft-Contact Blood Lancet market size was valued at US$ 990 million in 2025 and is forecast to a readjusted size of US$ 1343 million by 2032 with a CAGR of 4.5% during review period.
In 2025, the global annual production capacity of soft-contact blood lancets was approximately 19.5 billion units, while actual output reached around 16.03 billion units. The global average selling price was approximately US$0.060 per unit. Supported by large-scale automated manufacturing and stable demand from chronic disease management, major manufacturers maintained gross profit margins in the range of 30%–45%. Soft-contact blood lancets are disposable medical devices used for capillary blood sampling. They incorporate a soft-contact or pressure-activated mechanism that minimizes skin trauma and reduces pain during puncture while ensuring consistent penetration depth. These lancets are widely applied in blood glucose monitoring, point-of-care testing, and home healthcare scenarios.
Upstream of the soft-contact blood lancet supply chain consists of medical-grade stainless steel needles, polymer resins, spring components, packaging materials, and sterilization consumables. Midstream manufacturers focus on precision injection molding, needle grinding, automated assembly, sterilization, and quality control, with major production centers located in China, the United States, Europe, and Southeast Asia. Downstream channels include hospitals, diagnostic laboratories, pharmacies, medical distributors, and home healthcare brands. End users place strong emphasis on safety, pain reduction, sterility assurance, consistency, and compatibility with various lancing devices.
The soft-contact blood lancet market in 2025 is supported by the continued rise in diabetes prevalence and the expansion of home-based healthcare. Compared with traditional lancets, soft-contact designs provide better user comfort and improved sampling consistency, driving their gradual replacement of conventional products. Although unit prices remain relatively low, high shipment volumes and automated manufacturing enable suppliers to maintain stable margins. Regulatory compliance and sterilization standards remain key barriers to entry. Future growth will be driven by chronic disease management, aging populations, and increasing healthcare accessibility in emerging markets.
This report is a detailed and comprehensive analysis for global Soft-Contact Blood Lancet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Soft-Contact Blood Lancet market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Soft-Contact Blood Lancet market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Soft-Contact Blood Lancet market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Soft-Contact Blood Lancet market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Soft-Contact Blood Lancet
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Soft-Contact Blood Lancet market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Lifescan, BD, MTD Group, Greiner Bio One, Owen Mumford, Cardinal Health, Ascensia, Abbott, B. Braun, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Soft-Contact Blood Lancet market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Soft-Contact Blood Lancet product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Soft-Contact Blood Lancet, with price, sales quantity, revenue, and global market share of Soft-Contact Blood Lancet from 2021 to 2026.
Chapter 3, the Soft-Contact Blood Lancet competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Soft-Contact Blood Lancet breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Soft-Contact Blood Lancet market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Soft-Contact Blood Lancet.
Chapter 14 and 15, to describe Soft-Contact Blood Lancet sales channel, distributors, customers, research findings and conclusion.
In 2025, the global annual production capacity of soft-contact blood lancets was approximately 19.5 billion units, while actual output reached around 16.03 billion units. The global average selling price was approximately US$0.060 per unit. Supported by large-scale automated manufacturing and stable demand from chronic disease management, major manufacturers maintained gross profit margins in the range of 30%–45%. Soft-contact blood lancets are disposable medical devices used for capillary blood sampling. They incorporate a soft-contact or pressure-activated mechanism that minimizes skin trauma and reduces pain during puncture while ensuring consistent penetration depth. These lancets are widely applied in blood glucose monitoring, point-of-care testing, and home healthcare scenarios.
Upstream of the soft-contact blood lancet supply chain consists of medical-grade stainless steel needles, polymer resins, spring components, packaging materials, and sterilization consumables. Midstream manufacturers focus on precision injection molding, needle grinding, automated assembly, sterilization, and quality control, with major production centers located in China, the United States, Europe, and Southeast Asia. Downstream channels include hospitals, diagnostic laboratories, pharmacies, medical distributors, and home healthcare brands. End users place strong emphasis on safety, pain reduction, sterility assurance, consistency, and compatibility with various lancing devices.
The soft-contact blood lancet market in 2025 is supported by the continued rise in diabetes prevalence and the expansion of home-based healthcare. Compared with traditional lancets, soft-contact designs provide better user comfort and improved sampling consistency, driving their gradual replacement of conventional products. Although unit prices remain relatively low, high shipment volumes and automated manufacturing enable suppliers to maintain stable margins. Regulatory compliance and sterilization standards remain key barriers to entry. Future growth will be driven by chronic disease management, aging populations, and increasing healthcare accessibility in emerging markets.
This report is a detailed and comprehensive analysis for global Soft-Contact Blood Lancet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Soft-Contact Blood Lancet market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Soft-Contact Blood Lancet market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Soft-Contact Blood Lancet market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Soft-Contact Blood Lancet market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Soft-Contact Blood Lancet
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Soft-Contact Blood Lancet market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Lifescan, BD, MTD Group, Greiner Bio One, Owen Mumford, Cardinal Health, Ascensia, Abbott, B. Braun, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Soft-Contact Blood Lancet market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Safety
- Routine
- Standard Length
- Short-length
- Long-length
- Newborn Screening
- Blood Glucose Test
- Rapid Complete Blood Count
- Others
- Roche
- Lifescan
- BD
- MTD Group
- Greiner Bio One
- Owen Mumford
- Cardinal Health
- Ascensia
- Abbott
- B. Braun
- Terumo
- I-SENS
- Nipro
- ICU Medical
- Sarstedt
- Sannuo Biosensor
- Yuwell Medical
- Tianjin Huahong
- Suzhou Slink Medical
- Shandong Lianfa
- Puan Medical
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Soft-Contact Blood Lancet product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Soft-Contact Blood Lancet, with price, sales quantity, revenue, and global market share of Soft-Contact Blood Lancet from 2021 to 2026.
Chapter 3, the Soft-Contact Blood Lancet competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Soft-Contact Blood Lancet breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Soft-Contact Blood Lancet market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Soft-Contact Blood Lancet.
Chapter 14 and 15, to describe Soft-Contact Blood Lancet sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Soft-Contact Blood Lancet Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Safety
1.3.3 Routine
1.4 Market Analysis by Length
1.4.1 Overview: Global Soft-Contact Blood Lancet Consumption Value by Length: 2021 Versus 2025 Versus 2032
1.4.2 Standard Length
1.4.3 Short-length
1.4.4 Long-length
1.5 Market Analysis by Application
1.5.1 Overview: Global Soft-Contact Blood Lancet Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Newborn Screening
1.5.3 Blood Glucose Test
1.5.4 Rapid Complete Blood Count
1.5.5 Others
1.6 Global Soft-Contact Blood Lancet Market Size & Forecast
1.6.1 Global Soft-Contact Blood Lancet Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Soft-Contact Blood Lancet Sales Quantity (2021-2032)
1.6.3 Global Soft-Contact Blood Lancet Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Soft-Contact Blood Lancet Product and Services
2.1.4 Roche Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments/Updates
2.2 Lifescan
2.2.1 Lifescan Details
2.2.2 Lifescan Major Business
2.2.3 Lifescan Soft-Contact Blood Lancet Product and Services
2.2.4 Lifescan Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Lifescan Recent Developments/Updates
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business
2.3.3 BD Soft-Contact Blood Lancet Product and Services
2.3.4 BD Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 BD Recent Developments/Updates
2.4 MTD Group
2.4.1 MTD Group Details
2.4.2 MTD Group Major Business
2.4.3 MTD Group Soft-Contact Blood Lancet Product and Services
2.4.4 MTD Group Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 MTD Group Recent Developments/Updates
2.5 Greiner Bio One
2.5.1 Greiner Bio One Details
2.5.2 Greiner Bio One Major Business
2.5.3 Greiner Bio One Soft-Contact Blood Lancet Product and Services
2.5.4 Greiner Bio One Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Greiner Bio One Recent Developments/Updates
2.6 Owen Mumford
2.6.1 Owen Mumford Details
2.6.2 Owen Mumford Major Business
2.6.3 Owen Mumford Soft-Contact Blood Lancet Product and Services
2.6.4 Owen Mumford Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Owen Mumford Recent Developments/Updates
2.7 Cardinal Health
2.7.1 Cardinal Health Details
2.7.2 Cardinal Health Major Business
2.7.3 Cardinal Health Soft-Contact Blood Lancet Product and Services
2.7.4 Cardinal Health Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Cardinal Health Recent Developments/Updates
2.8 Ascensia
2.8.1 Ascensia Details
2.8.2 Ascensia Major Business
2.8.3 Ascensia Soft-Contact Blood Lancet Product and Services
2.8.4 Ascensia Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Ascensia Recent Developments/Updates
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Soft-Contact Blood Lancet Product and Services
2.9.4 Abbott Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Abbott Recent Developments/Updates
2.10 B. Braun
2.10.1 B. Braun Details
2.10.2 B. Braun Major Business
2.10.3 B. Braun Soft-Contact Blood Lancet Product and Services
2.10.4 B. Braun Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 B. Braun Recent Developments/Updates
2.11 Terumo
2.11.1 Terumo Details
2.11.2 Terumo Major Business
2.11.3 Terumo Soft-Contact Blood Lancet Product and Services
2.11.4 Terumo Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Terumo Recent Developments/Updates
2.12 I-SENS
2.12.1 I-SENS Details
2.12.2 I-SENS Major Business
2.12.3 I-SENS Soft-Contact Blood Lancet Product and Services
2.12.4 I-SENS Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 I-SENS Recent Developments/Updates
2.13 Nipro
2.13.1 Nipro Details
2.13.2 Nipro Major Business
2.13.3 Nipro Soft-Contact Blood Lancet Product and Services
2.13.4 Nipro Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Nipro Recent Developments/Updates
2.14 ICU Medical
2.14.1 ICU Medical Details
2.14.2 ICU Medical Major Business
2.14.3 ICU Medical Soft-Contact Blood Lancet Product and Services
2.14.4 ICU Medical Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 ICU Medical Recent Developments/Updates
2.15 Sarstedt
2.15.1 Sarstedt Details
2.15.2 Sarstedt Major Business
2.15.3 Sarstedt Soft-Contact Blood Lancet Product and Services
2.15.4 Sarstedt Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Sarstedt Recent Developments/Updates
2.16 Sannuo Biosensor
2.16.1 Sannuo Biosensor Details
2.16.2 Sannuo Biosensor Major Business
2.16.3 Sannuo Biosensor Soft-Contact Blood Lancet Product and Services
2.16.4 Sannuo Biosensor Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Sannuo Biosensor Recent Developments/Updates
2.17 Yuwell Medical
2.17.1 Yuwell Medical Details
2.17.2 Yuwell Medical Major Business
2.17.3 Yuwell Medical Soft-Contact Blood Lancet Product and Services
2.17.4 Yuwell Medical Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Yuwell Medical Recent Developments/Updates
2.18 Tianjin Huahong
2.18.1 Tianjin Huahong Details
2.18.2 Tianjin Huahong Major Business
2.18.3 Tianjin Huahong Soft-Contact Blood Lancet Product and Services
2.18.4 Tianjin Huahong Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Tianjin Huahong Recent Developments/Updates
2.19 Suzhou Slink Medical
2.19.1 Suzhou Slink Medical Details
2.19.2 Suzhou Slink Medical Major Business
2.19.3 Suzhou Slink Medical Soft-Contact Blood Lancet Product and Services
2.19.4 Suzhou Slink Medical Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Suzhou Slink Medical Recent Developments/Updates
2.20 Shandong Lianfa
2.20.1 Shandong Lianfa Details
2.20.2 Shandong Lianfa Major Business
2.20.3 Shandong Lianfa Soft-Contact Blood Lancet Product and Services
2.20.4 Shandong Lianfa Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Shandong Lianfa Recent Developments/Updates
2.21 Puan Medical
2.21.1 Puan Medical Details
2.21.2 Puan Medical Major Business
2.21.3 Puan Medical Soft-Contact Blood Lancet Product and Services
2.21.4 Puan Medical Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Puan Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SOFT-CONTACT BLOOD LANCET BY MANUFACTURER
3.1 Global Soft-Contact Blood Lancet Sales Quantity by Manufacturer (2021-2026)
3.2 Global Soft-Contact Blood Lancet Revenue by Manufacturer (2021-2026)
3.3 Global Soft-Contact Blood Lancet Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Soft-Contact Blood Lancet by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Soft-Contact Blood Lancet Manufacturer Market Share in 2025
3.4.3 Top 6 Soft-Contact Blood Lancet Manufacturer Market Share in 2025
3.5 Soft-Contact Blood Lancet Market: Overall Company Footprint Analysis
3.5.1 Soft-Contact Blood Lancet Market: Region Footprint
3.5.2 Soft-Contact Blood Lancet Market: Company Product Type Footprint
3.5.3 Soft-Contact Blood Lancet Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Soft-Contact Blood Lancet Market Size by Region
4.1.1 Global Soft-Contact Blood Lancet Sales Quantity by Region (2021-2032)
4.1.2 Global Soft-Contact Blood Lancet Consumption Value by Region (2021-2032)
4.1.3 Global Soft-Contact Blood Lancet Average Price by Region (2021-2032)
4.2 North America Soft-Contact Blood Lancet Consumption Value (2021-2032)
4.3 Europe Soft-Contact Blood Lancet Consumption Value (2021-2032)
4.4 Asia-Pacific Soft-Contact Blood Lancet Consumption Value (2021-2032)
4.5 South America Soft-Contact Blood Lancet Consumption Value (2021-2032)
4.6 Middle East & Africa Soft-Contact Blood Lancet Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Soft-Contact Blood Lancet Sales Quantity by Type (2021-2032)
5.2 Global Soft-Contact Blood Lancet Consumption Value by Type (2021-2032)
5.3 Global Soft-Contact Blood Lancet Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Soft-Contact Blood Lancet Sales Quantity by Application (2021-2032)
6.2 Global Soft-Contact Blood Lancet Consumption Value by Application (2021-2032)
6.3 Global Soft-Contact Blood Lancet Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Soft-Contact Blood Lancet Sales Quantity by Type (2021-2032)
7.2 North America Soft-Contact Blood Lancet Sales Quantity by Application (2021-2032)
7.3 North America Soft-Contact Blood Lancet Market Size by Country
7.3.1 North America Soft-Contact Blood Lancet Sales Quantity by Country (2021-2032)
7.3.2 North America Soft-Contact Blood Lancet Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Soft-Contact Blood Lancet Sales Quantity by Type (2021-2032)
8.2 Europe Soft-Contact Blood Lancet Sales Quantity by Application (2021-2032)
8.3 Europe Soft-Contact Blood Lancet Market Size by Country
8.3.1 Europe Soft-Contact Blood Lancet Sales Quantity by Country (2021-2032)
8.3.2 Europe Soft-Contact Blood Lancet Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Soft-Contact Blood Lancet Market Size by Region
9.3.1 Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Soft-Contact Blood Lancet Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Soft-Contact Blood Lancet Sales Quantity by Type (2021-2032)
10.2 South America Soft-Contact Blood Lancet Sales Quantity by Application (2021-2032)
10.3 South America Soft-Contact Blood Lancet Market Size by Country
10.3.1 South America Soft-Contact Blood Lancet Sales Quantity by Country (2021-2032)
10.3.2 South America Soft-Contact Blood Lancet Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Soft-Contact Blood Lancet Market Size by Country
11.3.1 Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Soft-Contact Blood Lancet Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Soft-Contact Blood Lancet Market Drivers
12.2 Soft-Contact Blood Lancet Market Restraints
12.3 Soft-Contact Blood Lancet Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Soft-Contact Blood Lancet and Key Manufacturers
13.2 Manufacturing Costs Percentage of Soft-Contact Blood Lancet
13.3 Soft-Contact Blood Lancet Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Soft-Contact Blood Lancet Typical Distributors
14.3 Soft-Contact Blood Lancet Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Soft-Contact Blood Lancet Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Safety
1.3.3 Routine
1.4 Market Analysis by Length
1.4.1 Overview: Global Soft-Contact Blood Lancet Consumption Value by Length: 2021 Versus 2025 Versus 2032
1.4.2 Standard Length
1.4.3 Short-length
1.4.4 Long-length
1.5 Market Analysis by Application
1.5.1 Overview: Global Soft-Contact Blood Lancet Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Newborn Screening
1.5.3 Blood Glucose Test
1.5.4 Rapid Complete Blood Count
1.5.5 Others
1.6 Global Soft-Contact Blood Lancet Market Size & Forecast
1.6.1 Global Soft-Contact Blood Lancet Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Soft-Contact Blood Lancet Sales Quantity (2021-2032)
1.6.3 Global Soft-Contact Blood Lancet Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Soft-Contact Blood Lancet Product and Services
2.1.4 Roche Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments/Updates
2.2 Lifescan
2.2.1 Lifescan Details
2.2.2 Lifescan Major Business
2.2.3 Lifescan Soft-Contact Blood Lancet Product and Services
2.2.4 Lifescan Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Lifescan Recent Developments/Updates
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business
2.3.3 BD Soft-Contact Blood Lancet Product and Services
2.3.4 BD Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 BD Recent Developments/Updates
2.4 MTD Group
2.4.1 MTD Group Details
2.4.2 MTD Group Major Business
2.4.3 MTD Group Soft-Contact Blood Lancet Product and Services
2.4.4 MTD Group Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 MTD Group Recent Developments/Updates
2.5 Greiner Bio One
2.5.1 Greiner Bio One Details
2.5.2 Greiner Bio One Major Business
2.5.3 Greiner Bio One Soft-Contact Blood Lancet Product and Services
2.5.4 Greiner Bio One Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Greiner Bio One Recent Developments/Updates
2.6 Owen Mumford
2.6.1 Owen Mumford Details
2.6.2 Owen Mumford Major Business
2.6.3 Owen Mumford Soft-Contact Blood Lancet Product and Services
2.6.4 Owen Mumford Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Owen Mumford Recent Developments/Updates
2.7 Cardinal Health
2.7.1 Cardinal Health Details
2.7.2 Cardinal Health Major Business
2.7.3 Cardinal Health Soft-Contact Blood Lancet Product and Services
2.7.4 Cardinal Health Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Cardinal Health Recent Developments/Updates
2.8 Ascensia
2.8.1 Ascensia Details
2.8.2 Ascensia Major Business
2.8.3 Ascensia Soft-Contact Blood Lancet Product and Services
2.8.4 Ascensia Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Ascensia Recent Developments/Updates
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Soft-Contact Blood Lancet Product and Services
2.9.4 Abbott Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Abbott Recent Developments/Updates
2.10 B. Braun
2.10.1 B. Braun Details
2.10.2 B. Braun Major Business
2.10.3 B. Braun Soft-Contact Blood Lancet Product and Services
2.10.4 B. Braun Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 B. Braun Recent Developments/Updates
2.11 Terumo
2.11.1 Terumo Details
2.11.2 Terumo Major Business
2.11.3 Terumo Soft-Contact Blood Lancet Product and Services
2.11.4 Terumo Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Terumo Recent Developments/Updates
2.12 I-SENS
2.12.1 I-SENS Details
2.12.2 I-SENS Major Business
2.12.3 I-SENS Soft-Contact Blood Lancet Product and Services
2.12.4 I-SENS Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 I-SENS Recent Developments/Updates
2.13 Nipro
2.13.1 Nipro Details
2.13.2 Nipro Major Business
2.13.3 Nipro Soft-Contact Blood Lancet Product and Services
2.13.4 Nipro Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Nipro Recent Developments/Updates
2.14 ICU Medical
2.14.1 ICU Medical Details
2.14.2 ICU Medical Major Business
2.14.3 ICU Medical Soft-Contact Blood Lancet Product and Services
2.14.4 ICU Medical Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 ICU Medical Recent Developments/Updates
2.15 Sarstedt
2.15.1 Sarstedt Details
2.15.2 Sarstedt Major Business
2.15.3 Sarstedt Soft-Contact Blood Lancet Product and Services
2.15.4 Sarstedt Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Sarstedt Recent Developments/Updates
2.16 Sannuo Biosensor
2.16.1 Sannuo Biosensor Details
2.16.2 Sannuo Biosensor Major Business
2.16.3 Sannuo Biosensor Soft-Contact Blood Lancet Product and Services
2.16.4 Sannuo Biosensor Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Sannuo Biosensor Recent Developments/Updates
2.17 Yuwell Medical
2.17.1 Yuwell Medical Details
2.17.2 Yuwell Medical Major Business
2.17.3 Yuwell Medical Soft-Contact Blood Lancet Product and Services
2.17.4 Yuwell Medical Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Yuwell Medical Recent Developments/Updates
2.18 Tianjin Huahong
2.18.1 Tianjin Huahong Details
2.18.2 Tianjin Huahong Major Business
2.18.3 Tianjin Huahong Soft-Contact Blood Lancet Product and Services
2.18.4 Tianjin Huahong Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Tianjin Huahong Recent Developments/Updates
2.19 Suzhou Slink Medical
2.19.1 Suzhou Slink Medical Details
2.19.2 Suzhou Slink Medical Major Business
2.19.3 Suzhou Slink Medical Soft-Contact Blood Lancet Product and Services
2.19.4 Suzhou Slink Medical Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Suzhou Slink Medical Recent Developments/Updates
2.20 Shandong Lianfa
2.20.1 Shandong Lianfa Details
2.20.2 Shandong Lianfa Major Business
2.20.3 Shandong Lianfa Soft-Contact Blood Lancet Product and Services
2.20.4 Shandong Lianfa Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Shandong Lianfa Recent Developments/Updates
2.21 Puan Medical
2.21.1 Puan Medical Details
2.21.2 Puan Medical Major Business
2.21.3 Puan Medical Soft-Contact Blood Lancet Product and Services
2.21.4 Puan Medical Soft-Contact Blood Lancet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Puan Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SOFT-CONTACT BLOOD LANCET BY MANUFACTURER
3.1 Global Soft-Contact Blood Lancet Sales Quantity by Manufacturer (2021-2026)
3.2 Global Soft-Contact Blood Lancet Revenue by Manufacturer (2021-2026)
3.3 Global Soft-Contact Blood Lancet Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Soft-Contact Blood Lancet by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Soft-Contact Blood Lancet Manufacturer Market Share in 2025
3.4.3 Top 6 Soft-Contact Blood Lancet Manufacturer Market Share in 2025
3.5 Soft-Contact Blood Lancet Market: Overall Company Footprint Analysis
3.5.1 Soft-Contact Blood Lancet Market: Region Footprint
3.5.2 Soft-Contact Blood Lancet Market: Company Product Type Footprint
3.5.3 Soft-Contact Blood Lancet Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Soft-Contact Blood Lancet Market Size by Region
4.1.1 Global Soft-Contact Blood Lancet Sales Quantity by Region (2021-2032)
4.1.2 Global Soft-Contact Blood Lancet Consumption Value by Region (2021-2032)
4.1.3 Global Soft-Contact Blood Lancet Average Price by Region (2021-2032)
4.2 North America Soft-Contact Blood Lancet Consumption Value (2021-2032)
4.3 Europe Soft-Contact Blood Lancet Consumption Value (2021-2032)
4.4 Asia-Pacific Soft-Contact Blood Lancet Consumption Value (2021-2032)
4.5 South America Soft-Contact Blood Lancet Consumption Value (2021-2032)
4.6 Middle East & Africa Soft-Contact Blood Lancet Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Soft-Contact Blood Lancet Sales Quantity by Type (2021-2032)
5.2 Global Soft-Contact Blood Lancet Consumption Value by Type (2021-2032)
5.3 Global Soft-Contact Blood Lancet Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Soft-Contact Blood Lancet Sales Quantity by Application (2021-2032)
6.2 Global Soft-Contact Blood Lancet Consumption Value by Application (2021-2032)
6.3 Global Soft-Contact Blood Lancet Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Soft-Contact Blood Lancet Sales Quantity by Type (2021-2032)
7.2 North America Soft-Contact Blood Lancet Sales Quantity by Application (2021-2032)
7.3 North America Soft-Contact Blood Lancet Market Size by Country
7.3.1 North America Soft-Contact Blood Lancet Sales Quantity by Country (2021-2032)
7.3.2 North America Soft-Contact Blood Lancet Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Soft-Contact Blood Lancet Sales Quantity by Type (2021-2032)
8.2 Europe Soft-Contact Blood Lancet Sales Quantity by Application (2021-2032)
8.3 Europe Soft-Contact Blood Lancet Market Size by Country
8.3.1 Europe Soft-Contact Blood Lancet Sales Quantity by Country (2021-2032)
8.3.2 Europe Soft-Contact Blood Lancet Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Soft-Contact Blood Lancet Market Size by Region
9.3.1 Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Soft-Contact Blood Lancet Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Soft-Contact Blood Lancet Sales Quantity by Type (2021-2032)
10.2 South America Soft-Contact Blood Lancet Sales Quantity by Application (2021-2032)
10.3 South America Soft-Contact Blood Lancet Market Size by Country
10.3.1 South America Soft-Contact Blood Lancet Sales Quantity by Country (2021-2032)
10.3.2 South America Soft-Contact Blood Lancet Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Soft-Contact Blood Lancet Market Size by Country
11.3.1 Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Soft-Contact Blood Lancet Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Soft-Contact Blood Lancet Market Drivers
12.2 Soft-Contact Blood Lancet Market Restraints
12.3 Soft-Contact Blood Lancet Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Soft-Contact Blood Lancet and Key Manufacturers
13.2 Manufacturing Costs Percentage of Soft-Contact Blood Lancet
13.3 Soft-Contact Blood Lancet Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Soft-Contact Blood Lancet Typical Distributors
14.3 Soft-Contact Blood Lancet Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Soft-Contact Blood Lancet Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Soft-Contact Blood Lancet Consumption Value by Length, (USD Million), 2021 & 2025 & 2032
Table 3. Global Soft-Contact Blood Lancet Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Roche Basic Information, Manufacturing Base and Competitors
Table 5. Roche Major Business
Table 6. Roche Soft-Contact Blood Lancet Product and Services
Table 7. Roche Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Roche Recent Developments/Updates
Table 9. Lifescan Basic Information, Manufacturing Base and Competitors
Table 10. Lifescan Major Business
Table 11. Lifescan Soft-Contact Blood Lancet Product and Services
Table 12. Lifescan Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Lifescan Recent Developments/Updates
Table 14. BD Basic Information, Manufacturing Base and Competitors
Table 15. BD Major Business
Table 16. BD Soft-Contact Blood Lancet Product and Services
Table 17. BD Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. BD Recent Developments/Updates
Table 19. MTD Group Basic Information, Manufacturing Base and Competitors
Table 20. MTD Group Major Business
Table 21. MTD Group Soft-Contact Blood Lancet Product and Services
Table 22. MTD Group Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. MTD Group Recent Developments/Updates
Table 24. Greiner Bio One Basic Information, Manufacturing Base and Competitors
Table 25. Greiner Bio One Major Business
Table 26. Greiner Bio One Soft-Contact Blood Lancet Product and Services
Table 27. Greiner Bio One Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Greiner Bio One Recent Developments/Updates
Table 29. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 30. Owen Mumford Major Business
Table 31. Owen Mumford Soft-Contact Blood Lancet Product and Services
Table 32. Owen Mumford Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Owen Mumford Recent Developments/Updates
Table 34. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 35. Cardinal Health Major Business
Table 36. Cardinal Health Soft-Contact Blood Lancet Product and Services
Table 37. Cardinal Health Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Cardinal Health Recent Developments/Updates
Table 39. Ascensia Basic Information, Manufacturing Base and Competitors
Table 40. Ascensia Major Business
Table 41. Ascensia Soft-Contact Blood Lancet Product and Services
Table 42. Ascensia Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Ascensia Recent Developments/Updates
Table 44. Abbott Basic Information, Manufacturing Base and Competitors
Table 45. Abbott Major Business
Table 46. Abbott Soft-Contact Blood Lancet Product and Services
Table 47. Abbott Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Abbott Recent Developments/Updates
Table 49. B. Braun Basic Information, Manufacturing Base and Competitors
Table 50. B. Braun Major Business
Table 51. B. Braun Soft-Contact Blood Lancet Product and Services
Table 52. B. Braun Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. B. Braun Recent Developments/Updates
Table 54. Terumo Basic Information, Manufacturing Base and Competitors
Table 55. Terumo Major Business
Table 56. Terumo Soft-Contact Blood Lancet Product and Services
Table 57. Terumo Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Terumo Recent Developments/Updates
Table 59. I-SENS Basic Information, Manufacturing Base and Competitors
Table 60. I-SENS Major Business
Table 61. I-SENS Soft-Contact Blood Lancet Product and Services
Table 62. I-SENS Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. I-SENS Recent Developments/Updates
Table 64. Nipro Basic Information, Manufacturing Base and Competitors
Table 65. Nipro Major Business
Table 66. Nipro Soft-Contact Blood Lancet Product and Services
Table 67. Nipro Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Nipro Recent Developments/Updates
Table 69. ICU Medical Basic Information, Manufacturing Base and Competitors
Table 70. ICU Medical Major Business
Table 71. ICU Medical Soft-Contact Blood Lancet Product and Services
Table 72. ICU Medical Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. ICU Medical Recent Developments/Updates
Table 74. Sarstedt Basic Information, Manufacturing Base and Competitors
Table 75. Sarstedt Major Business
Table 76. Sarstedt Soft-Contact Blood Lancet Product and Services
Table 77. Sarstedt Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Sarstedt Recent Developments/Updates
Table 79. Sannuo Biosensor Basic Information, Manufacturing Base and Competitors
Table 80. Sannuo Biosensor Major Business
Table 81. Sannuo Biosensor Soft-Contact Blood Lancet Product and Services
Table 82. Sannuo Biosensor Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Sannuo Biosensor Recent Developments/Updates
Table 84. Yuwell Medical Basic Information, Manufacturing Base and Competitors
Table 85. Yuwell Medical Major Business
Table 86. Yuwell Medical Soft-Contact Blood Lancet Product and Services
Table 87. Yuwell Medical Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 88. Yuwell Medical Recent Developments/Updates
Table 89. Tianjin Huahong Basic Information, Manufacturing Base and Competitors
Table 90. Tianjin Huahong Major Business
Table 91. Tianjin Huahong Soft-Contact Blood Lancet Product and Services
Table 92. Tianjin Huahong Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 93. Tianjin Huahong Recent Developments/Updates
Table 94. Suzhou Slink Medical Basic Information, Manufacturing Base and Competitors
Table 95. Suzhou Slink Medical Major Business
Table 96. Suzhou Slink Medical Soft-Contact Blood Lancet Product and Services
Table 97. Suzhou Slink Medical Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Suzhou Slink Medical Recent Developments/Updates
Table 99. Shandong Lianfa Basic Information, Manufacturing Base and Competitors
Table 100. Shandong Lianfa Major Business
Table 101. Shandong Lianfa Soft-Contact Blood Lancet Product and Services
Table 102. Shandong Lianfa Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Shandong Lianfa Recent Developments/Updates
Table 104. Puan Medical Basic Information, Manufacturing Base and Competitors
Table 105. Puan Medical Major Business
Table 106. Puan Medical Soft-Contact Blood Lancet Product and Services
Table 107. Puan Medical Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Puan Medical Recent Developments/Updates
Table 109. Global Soft-Contact Blood Lancet Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 110. Global Soft-Contact Blood Lancet Revenue by Manufacturer (2021-2026) & (USD Million)
Table 111. Global Soft-Contact Blood Lancet Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 112. Market Position of Manufacturers in Soft-Contact Blood Lancet, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 113. Head Office and Soft-Contact Blood Lancet Production Site of Key Manufacturer
Table 114. Soft-Contact Blood Lancet Market: Company Product Type Footprint
Table 115. Soft-Contact Blood Lancet Market: Company Product Application Footprint
Table 116. Soft-Contact Blood Lancet New Market Entrants and Barriers to Market Entry
Table 117. Soft-Contact Blood Lancet Mergers, Acquisition, Agreements, and Collaborations
Table 118. Global Soft-Contact Blood Lancet Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 119. Global Soft-Contact Blood Lancet Sales Quantity by Region (2021-2026) & (K Units)
Table 120. Global Soft-Contact Blood Lancet Sales Quantity by Region (2027-2032) & (K Units)
Table 121. Global Soft-Contact Blood Lancet Consumption Value by Region (2021-2026) & (USD Million)
Table 122. Global Soft-Contact Blood Lancet Consumption Value by Region (2027-2032) & (USD Million)
Table 123. Global Soft-Contact Blood Lancet Average Price by Region (2021-2026) & (US$/Unit)
Table 124. Global Soft-Contact Blood Lancet Average Price by Region (2027-2032) & (US$/Unit)
Table 125. Global Soft-Contact Blood Lancet Sales Quantity by Type (2021-2026) & (K Units)
Table 126. Global Soft-Contact Blood Lancet Sales Quantity by Type (2027-2032) & (K Units)
Table 127. Global Soft-Contact Blood Lancet Consumption Value by Type (2021-2026) & (USD Million)
Table 128. Global Soft-Contact Blood Lancet Consumption Value by Type (2027-2032) & (USD Million)
Table 129. Global Soft-Contact Blood Lancet Average Price by Type (2021-2026) & (US$/Unit)
Table 130. Global Soft-Contact Blood Lancet Average Price by Type (2027-2032) & (US$/Unit)
Table 131. Global Soft-Contact Blood Lancet Sales Quantity by Application (2021-2026) & (K Units)
Table 132. Global Soft-Contact Blood Lancet Sales Quantity by Application (2027-2032) & (K Units)
Table 133. Global Soft-Contact Blood Lancet Consumption Value by Application (2021-2026) & (USD Million)
Table 134. Global Soft-Contact Blood Lancet Consumption Value by Application (2027-2032) & (USD Million)
Table 135. Global Soft-Contact Blood Lancet Average Price by Application (2021-2026) & (US$/Unit)
Table 136. Global Soft-Contact Blood Lancet Average Price by Application (2027-2032) & (US$/Unit)
Table 137. North America Soft-Contact Blood Lancet Sales Quantity by Type (2021-2026) & (K Units)
Table 138. North America Soft-Contact Blood Lancet Sales Quantity by Type (2027-2032) & (K Units)
Table 139. North America Soft-Contact Blood Lancet Sales Quantity by Application (2021-2026) & (K Units)
Table 140. North America Soft-Contact Blood Lancet Sales Quantity by Application (2027-2032) & (K Units)
Table 141. North America Soft-Contact Blood Lancet Sales Quantity by Country (2021-2026) & (K Units)
Table 142. North America Soft-Contact Blood Lancet Sales Quantity by Country (2027-2032) & (K Units)
Table 143. North America Soft-Contact Blood Lancet Consumption Value by Country (2021-2026) & (USD Million)
Table 144. North America Soft-Contact Blood Lancet Consumption Value by Country (2027-2032) & (USD Million)
Table 145. Europe Soft-Contact Blood Lancet Sales Quantity by Type (2021-2026) & (K Units)
Table 146. Europe Soft-Contact Blood Lancet Sales Quantity by Type (2027-2032) & (K Units)
Table 147. Europe Soft-Contact Blood Lancet Sales Quantity by Application (2021-2026) & (K Units)
Table 148. Europe Soft-Contact Blood Lancet Sales Quantity by Application (2027-2032) & (K Units)
Table 149. Europe Soft-Contact Blood Lancet Sales Quantity by Country (2021-2026) & (K Units)
Table 150. Europe Soft-Contact Blood Lancet Sales Quantity by Country (2027-2032) & (K Units)
Table 151. Europe Soft-Contact Blood Lancet Consumption Value by Country (2021-2026) & (USD Million)
Table 152. Europe Soft-Contact Blood Lancet Consumption Value by Country (2027-2032) & (USD Million)
Table 153. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Type (2021-2026) & (K Units)
Table 154. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Type (2027-2032) & (K Units)
Table 155. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Application (2021-2026) & (K Units)
Table 156. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Application (2027-2032) & (K Units)
Table 157. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Region (2021-2026) & (K Units)
Table 158. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Region (2027-2032) & (K Units)
Table 159. Asia-Pacific Soft-Contact Blood Lancet Consumption Value by Region (2021-2026) & (USD Million)
Table 160. Asia-Pacific Soft-Contact Blood Lancet Consumption Value by Region (2027-2032) & (USD Million)
Table 161. South America Soft-Contact Blood Lancet Sales Quantity by Type (2021-2026) & (K Units)
Table 162. South America Soft-Contact Blood Lancet Sales Quantity by Type (2027-2032) & (K Units)
Table 163. South America Soft-Contact Blood Lancet Sales Quantity by Application (2021-2026) & (K Units)
Table 164. South America Soft-Contact Blood Lancet Sales Quantity by Application (2027-2032) & (K Units)
Table 165. South America Soft-Contact Blood Lancet Sales Quantity by Country (2021-2026) & (K Units)
Table 166. South America Soft-Contact Blood Lancet Sales Quantity by Country (2027-2032) & (K Units)
Table 167. South America Soft-Contact Blood Lancet Consumption Value by Country (2021-2026) & (USD Million)
Table 168. South America Soft-Contact Blood Lancet Consumption Value by Country (2027-2032) & (USD Million)
Table 169. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Type (2021-2026) & (K Units)
Table 170. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Type (2027-2032) & (K Units)
Table 171. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Application (2021-2026) & (K Units)
Table 172. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Application (2027-2032) & (K Units)
Table 173. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Country (2021-2026) & (K Units)
Table 174. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Country (2027-2032) & (K Units)
Table 175. Middle East & Africa Soft-Contact Blood Lancet Consumption Value by Country (2021-2026) & (USD Million)
Table 176. Middle East & Africa Soft-Contact Blood Lancet Consumption Value by Country (2027-2032) & (USD Million)
Table 177. Soft-Contact Blood Lancet Raw Material
Table 178. Key Manufacturers of Soft-Contact Blood Lancet Raw Materials
Table 179. Soft-Contact Blood Lancet Typical Distributors
Table 180. Soft-Contact Blood Lancet Typical Customers
Table 1. Global Soft-Contact Blood Lancet Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Soft-Contact Blood Lancet Consumption Value by Length, (USD Million), 2021 & 2025 & 2032
Table 3. Global Soft-Contact Blood Lancet Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Roche Basic Information, Manufacturing Base and Competitors
Table 5. Roche Major Business
Table 6. Roche Soft-Contact Blood Lancet Product and Services
Table 7. Roche Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Roche Recent Developments/Updates
Table 9. Lifescan Basic Information, Manufacturing Base and Competitors
Table 10. Lifescan Major Business
Table 11. Lifescan Soft-Contact Blood Lancet Product and Services
Table 12. Lifescan Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Lifescan Recent Developments/Updates
Table 14. BD Basic Information, Manufacturing Base and Competitors
Table 15. BD Major Business
Table 16. BD Soft-Contact Blood Lancet Product and Services
Table 17. BD Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. BD Recent Developments/Updates
Table 19. MTD Group Basic Information, Manufacturing Base and Competitors
Table 20. MTD Group Major Business
Table 21. MTD Group Soft-Contact Blood Lancet Product and Services
Table 22. MTD Group Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. MTD Group Recent Developments/Updates
Table 24. Greiner Bio One Basic Information, Manufacturing Base and Competitors
Table 25. Greiner Bio One Major Business
Table 26. Greiner Bio One Soft-Contact Blood Lancet Product and Services
Table 27. Greiner Bio One Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Greiner Bio One Recent Developments/Updates
Table 29. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 30. Owen Mumford Major Business
Table 31. Owen Mumford Soft-Contact Blood Lancet Product and Services
Table 32. Owen Mumford Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Owen Mumford Recent Developments/Updates
Table 34. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 35. Cardinal Health Major Business
Table 36. Cardinal Health Soft-Contact Blood Lancet Product and Services
Table 37. Cardinal Health Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Cardinal Health Recent Developments/Updates
Table 39. Ascensia Basic Information, Manufacturing Base and Competitors
Table 40. Ascensia Major Business
Table 41. Ascensia Soft-Contact Blood Lancet Product and Services
Table 42. Ascensia Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Ascensia Recent Developments/Updates
Table 44. Abbott Basic Information, Manufacturing Base and Competitors
Table 45. Abbott Major Business
Table 46. Abbott Soft-Contact Blood Lancet Product and Services
Table 47. Abbott Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Abbott Recent Developments/Updates
Table 49. B. Braun Basic Information, Manufacturing Base and Competitors
Table 50. B. Braun Major Business
Table 51. B. Braun Soft-Contact Blood Lancet Product and Services
Table 52. B. Braun Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. B. Braun Recent Developments/Updates
Table 54. Terumo Basic Information, Manufacturing Base and Competitors
Table 55. Terumo Major Business
Table 56. Terumo Soft-Contact Blood Lancet Product and Services
Table 57. Terumo Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Terumo Recent Developments/Updates
Table 59. I-SENS Basic Information, Manufacturing Base and Competitors
Table 60. I-SENS Major Business
Table 61. I-SENS Soft-Contact Blood Lancet Product and Services
Table 62. I-SENS Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. I-SENS Recent Developments/Updates
Table 64. Nipro Basic Information, Manufacturing Base and Competitors
Table 65. Nipro Major Business
Table 66. Nipro Soft-Contact Blood Lancet Product and Services
Table 67. Nipro Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Nipro Recent Developments/Updates
Table 69. ICU Medical Basic Information, Manufacturing Base and Competitors
Table 70. ICU Medical Major Business
Table 71. ICU Medical Soft-Contact Blood Lancet Product and Services
Table 72. ICU Medical Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. ICU Medical Recent Developments/Updates
Table 74. Sarstedt Basic Information, Manufacturing Base and Competitors
Table 75. Sarstedt Major Business
Table 76. Sarstedt Soft-Contact Blood Lancet Product and Services
Table 77. Sarstedt Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Sarstedt Recent Developments/Updates
Table 79. Sannuo Biosensor Basic Information, Manufacturing Base and Competitors
Table 80. Sannuo Biosensor Major Business
Table 81. Sannuo Biosensor Soft-Contact Blood Lancet Product and Services
Table 82. Sannuo Biosensor Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Sannuo Biosensor Recent Developments/Updates
Table 84. Yuwell Medical Basic Information, Manufacturing Base and Competitors
Table 85. Yuwell Medical Major Business
Table 86. Yuwell Medical Soft-Contact Blood Lancet Product and Services
Table 87. Yuwell Medical Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 88. Yuwell Medical Recent Developments/Updates
Table 89. Tianjin Huahong Basic Information, Manufacturing Base and Competitors
Table 90. Tianjin Huahong Major Business
Table 91. Tianjin Huahong Soft-Contact Blood Lancet Product and Services
Table 92. Tianjin Huahong Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 93. Tianjin Huahong Recent Developments/Updates
Table 94. Suzhou Slink Medical Basic Information, Manufacturing Base and Competitors
Table 95. Suzhou Slink Medical Major Business
Table 96. Suzhou Slink Medical Soft-Contact Blood Lancet Product and Services
Table 97. Suzhou Slink Medical Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Suzhou Slink Medical Recent Developments/Updates
Table 99. Shandong Lianfa Basic Information, Manufacturing Base and Competitors
Table 100. Shandong Lianfa Major Business
Table 101. Shandong Lianfa Soft-Contact Blood Lancet Product and Services
Table 102. Shandong Lianfa Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Shandong Lianfa Recent Developments/Updates
Table 104. Puan Medical Basic Information, Manufacturing Base and Competitors
Table 105. Puan Medical Major Business
Table 106. Puan Medical Soft-Contact Blood Lancet Product and Services
Table 107. Puan Medical Soft-Contact Blood Lancet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Puan Medical Recent Developments/Updates
Table 109. Global Soft-Contact Blood Lancet Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 110. Global Soft-Contact Blood Lancet Revenue by Manufacturer (2021-2026) & (USD Million)
Table 111. Global Soft-Contact Blood Lancet Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 112. Market Position of Manufacturers in Soft-Contact Blood Lancet, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 113. Head Office and Soft-Contact Blood Lancet Production Site of Key Manufacturer
Table 114. Soft-Contact Blood Lancet Market: Company Product Type Footprint
Table 115. Soft-Contact Blood Lancet Market: Company Product Application Footprint
Table 116. Soft-Contact Blood Lancet New Market Entrants and Barriers to Market Entry
Table 117. Soft-Contact Blood Lancet Mergers, Acquisition, Agreements, and Collaborations
Table 118. Global Soft-Contact Blood Lancet Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 119. Global Soft-Contact Blood Lancet Sales Quantity by Region (2021-2026) & (K Units)
Table 120. Global Soft-Contact Blood Lancet Sales Quantity by Region (2027-2032) & (K Units)
Table 121. Global Soft-Contact Blood Lancet Consumption Value by Region (2021-2026) & (USD Million)
Table 122. Global Soft-Contact Blood Lancet Consumption Value by Region (2027-2032) & (USD Million)
Table 123. Global Soft-Contact Blood Lancet Average Price by Region (2021-2026) & (US$/Unit)
Table 124. Global Soft-Contact Blood Lancet Average Price by Region (2027-2032) & (US$/Unit)
Table 125. Global Soft-Contact Blood Lancet Sales Quantity by Type (2021-2026) & (K Units)
Table 126. Global Soft-Contact Blood Lancet Sales Quantity by Type (2027-2032) & (K Units)
Table 127. Global Soft-Contact Blood Lancet Consumption Value by Type (2021-2026) & (USD Million)
Table 128. Global Soft-Contact Blood Lancet Consumption Value by Type (2027-2032) & (USD Million)
Table 129. Global Soft-Contact Blood Lancet Average Price by Type (2021-2026) & (US$/Unit)
Table 130. Global Soft-Contact Blood Lancet Average Price by Type (2027-2032) & (US$/Unit)
Table 131. Global Soft-Contact Blood Lancet Sales Quantity by Application (2021-2026) & (K Units)
Table 132. Global Soft-Contact Blood Lancet Sales Quantity by Application (2027-2032) & (K Units)
Table 133. Global Soft-Contact Blood Lancet Consumption Value by Application (2021-2026) & (USD Million)
Table 134. Global Soft-Contact Blood Lancet Consumption Value by Application (2027-2032) & (USD Million)
Table 135. Global Soft-Contact Blood Lancet Average Price by Application (2021-2026) & (US$/Unit)
Table 136. Global Soft-Contact Blood Lancet Average Price by Application (2027-2032) & (US$/Unit)
Table 137. North America Soft-Contact Blood Lancet Sales Quantity by Type (2021-2026) & (K Units)
Table 138. North America Soft-Contact Blood Lancet Sales Quantity by Type (2027-2032) & (K Units)
Table 139. North America Soft-Contact Blood Lancet Sales Quantity by Application (2021-2026) & (K Units)
Table 140. North America Soft-Contact Blood Lancet Sales Quantity by Application (2027-2032) & (K Units)
Table 141. North America Soft-Contact Blood Lancet Sales Quantity by Country (2021-2026) & (K Units)
Table 142. North America Soft-Contact Blood Lancet Sales Quantity by Country (2027-2032) & (K Units)
Table 143. North America Soft-Contact Blood Lancet Consumption Value by Country (2021-2026) & (USD Million)
Table 144. North America Soft-Contact Blood Lancet Consumption Value by Country (2027-2032) & (USD Million)
Table 145. Europe Soft-Contact Blood Lancet Sales Quantity by Type (2021-2026) & (K Units)
Table 146. Europe Soft-Contact Blood Lancet Sales Quantity by Type (2027-2032) & (K Units)
Table 147. Europe Soft-Contact Blood Lancet Sales Quantity by Application (2021-2026) & (K Units)
Table 148. Europe Soft-Contact Blood Lancet Sales Quantity by Application (2027-2032) & (K Units)
Table 149. Europe Soft-Contact Blood Lancet Sales Quantity by Country (2021-2026) & (K Units)
Table 150. Europe Soft-Contact Blood Lancet Sales Quantity by Country (2027-2032) & (K Units)
Table 151. Europe Soft-Contact Blood Lancet Consumption Value by Country (2021-2026) & (USD Million)
Table 152. Europe Soft-Contact Blood Lancet Consumption Value by Country (2027-2032) & (USD Million)
Table 153. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Type (2021-2026) & (K Units)
Table 154. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Type (2027-2032) & (K Units)
Table 155. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Application (2021-2026) & (K Units)
Table 156. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Application (2027-2032) & (K Units)
Table 157. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Region (2021-2026) & (K Units)
Table 158. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity by Region (2027-2032) & (K Units)
Table 159. Asia-Pacific Soft-Contact Blood Lancet Consumption Value by Region (2021-2026) & (USD Million)
Table 160. Asia-Pacific Soft-Contact Blood Lancet Consumption Value by Region (2027-2032) & (USD Million)
Table 161. South America Soft-Contact Blood Lancet Sales Quantity by Type (2021-2026) & (K Units)
Table 162. South America Soft-Contact Blood Lancet Sales Quantity by Type (2027-2032) & (K Units)
Table 163. South America Soft-Contact Blood Lancet Sales Quantity by Application (2021-2026) & (K Units)
Table 164. South America Soft-Contact Blood Lancet Sales Quantity by Application (2027-2032) & (K Units)
Table 165. South America Soft-Contact Blood Lancet Sales Quantity by Country (2021-2026) & (K Units)
Table 166. South America Soft-Contact Blood Lancet Sales Quantity by Country (2027-2032) & (K Units)
Table 167. South America Soft-Contact Blood Lancet Consumption Value by Country (2021-2026) & (USD Million)
Table 168. South America Soft-Contact Blood Lancet Consumption Value by Country (2027-2032) & (USD Million)
Table 169. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Type (2021-2026) & (K Units)
Table 170. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Type (2027-2032) & (K Units)
Table 171. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Application (2021-2026) & (K Units)
Table 172. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Application (2027-2032) & (K Units)
Table 173. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Country (2021-2026) & (K Units)
Table 174. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity by Country (2027-2032) & (K Units)
Table 175. Middle East & Africa Soft-Contact Blood Lancet Consumption Value by Country (2021-2026) & (USD Million)
Table 176. Middle East & Africa Soft-Contact Blood Lancet Consumption Value by Country (2027-2032) & (USD Million)
Table 177. Soft-Contact Blood Lancet Raw Material
Table 178. Key Manufacturers of Soft-Contact Blood Lancet Raw Materials
Table 179. Soft-Contact Blood Lancet Typical Distributors
Table 180. Soft-Contact Blood Lancet Typical Customers
LIST OF FIGURES
Figure 1. Soft-Contact Blood Lancet Picture
Figure 2. Global Soft-Contact Blood Lancet Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Soft-Contact Blood Lancet Revenue Market Share by Type in 2025
Figure 4. Safety Examples
Figure 5. Routine Examples
Figure 6. Global Soft-Contact Blood Lancet Revenue by Length, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Soft-Contact Blood Lancet Revenue Market Share by Length in 2025
Figure 8. Standard Length Examples
Figure 9. Short-length Examples
Figure 10. Long-length Examples
Figure 11. Global Soft-Contact Blood Lancet Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Soft-Contact Blood Lancet Revenue Market Share by Application in 2025
Figure 13. Newborn Screening Examples
Figure 14. Blood Glucose Test Examples
Figure 15. Rapid Complete Blood Count Examples
Figure 16. Others Examples
Figure 17. Global Soft-Contact Blood Lancet Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 18. Global Soft-Contact Blood Lancet Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 19. Global Soft-Contact Blood Lancet Sales Quantity (2021-2032) & (K Units)
Figure 20. Global Soft-Contact Blood Lancet Price (2021-2032) & (US$/Unit)
Figure 21. Global Soft-Contact Blood Lancet Sales Quantity Market Share by Manufacturer in 2025
Figure 22. Global Soft-Contact Blood Lancet Revenue Market Share by Manufacturer in 2025
Figure 23. Producer Shipments of Soft-Contact Blood Lancet by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 24. Top 3 Soft-Contact Blood Lancet Manufacturer (Revenue) Market Share in 2025
Figure 25. Top 6 Soft-Contact Blood Lancet Manufacturer (Revenue) Market Share in 2025
Figure 26. Global Soft-Contact Blood Lancet Sales Quantity Market Share by Region (2021-2032)
Figure 27. Global Soft-Contact Blood Lancet Consumption Value Market Share by Region (2021-2032)
Figure 28. North America Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 33. Global Soft-Contact Blood Lancet Sales Quantity Market Share by Type (2021-2032)
Figure 34. Global Soft-Contact Blood Lancet Consumption Value Market Share by Type (2021-2032)
Figure 35. Global Soft-Contact Blood Lancet Average Price by Type (2021-2032) & (US$/Unit)
Figure 36. Global Soft-Contact Blood Lancet Sales Quantity Market Share by Application (2021-2032)
Figure 37. Global Soft-Contact Blood Lancet Revenue Market Share by Application (2021-2032)
Figure 38. Global Soft-Contact Blood Lancet Average Price by Application (2021-2032) & (US$/Unit)
Figure 39. North America Soft-Contact Blood Lancet Sales Quantity Market Share by Type (2021-2032)
Figure 40. North America Soft-Contact Blood Lancet Sales Quantity Market Share by Application (2021-2032)
Figure 41. North America Soft-Contact Blood Lancet Sales Quantity Market Share by Country (2021-2032)
Figure 42. North America Soft-Contact Blood Lancet Consumption Value Market Share by Country (2021-2032)
Figure 43. United States Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 44. Canada Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 45. Mexico Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 46. Europe Soft-Contact Blood Lancet Sales Quantity Market Share by Type (2021-2032)
Figure 47. Europe Soft-Contact Blood Lancet Sales Quantity Market Share by Application (2021-2032)
Figure 48. Europe Soft-Contact Blood Lancet Sales Quantity Market Share by Country (2021-2032)
Figure 49. Europe Soft-Contact Blood Lancet Consumption Value Market Share by Country (2021-2032)
Figure 50. Germany Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 51. France Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 52. United Kingdom Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 53. Russia Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 54. Italy Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity Market Share by Type (2021-2032)
Figure 56. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity Market Share by Application (2021-2032)
Figure 57. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity Market Share by Region (2021-2032)
Figure 58. Asia-Pacific Soft-Contact Blood Lancet Consumption Value Market Share by Region (2021-2032)
Figure 59. China Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 62. India Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Soft-Contact Blood Lancet Sales Quantity Market Share by Type (2021-2032)
Figure 66. South America Soft-Contact Blood Lancet Sales Quantity Market Share by Application (2021-2032)
Figure 67. South America Soft-Contact Blood Lancet Sales Quantity Market Share by Country (2021-2032)
Figure 68. South America Soft-Contact Blood Lancet Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity Market Share by Country (2021-2032)
Figure 74. Middle East & Africa Soft-Contact Blood Lancet Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 76. Egypt Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 77. Saudi Arabia Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 78. South Africa Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 79. Soft-Contact Blood Lancet Market Drivers
Figure 80. Soft-Contact Blood Lancet Market Restraints
Figure 81. Soft-Contact Blood Lancet Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Soft-Contact Blood Lancet in 2025
Figure 84. Manufacturing Process Analysis of Soft-Contact Blood Lancet
Figure 85. Soft-Contact Blood Lancet Industrial Chain
Figure 86. Sales Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
Figure 1. Soft-Contact Blood Lancet Picture
Figure 2. Global Soft-Contact Blood Lancet Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Soft-Contact Blood Lancet Revenue Market Share by Type in 2025
Figure 4. Safety Examples
Figure 5. Routine Examples
Figure 6. Global Soft-Contact Blood Lancet Revenue by Length, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Soft-Contact Blood Lancet Revenue Market Share by Length in 2025
Figure 8. Standard Length Examples
Figure 9. Short-length Examples
Figure 10. Long-length Examples
Figure 11. Global Soft-Contact Blood Lancet Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Soft-Contact Blood Lancet Revenue Market Share by Application in 2025
Figure 13. Newborn Screening Examples
Figure 14. Blood Glucose Test Examples
Figure 15. Rapid Complete Blood Count Examples
Figure 16. Others Examples
Figure 17. Global Soft-Contact Blood Lancet Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 18. Global Soft-Contact Blood Lancet Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 19. Global Soft-Contact Blood Lancet Sales Quantity (2021-2032) & (K Units)
Figure 20. Global Soft-Contact Blood Lancet Price (2021-2032) & (US$/Unit)
Figure 21. Global Soft-Contact Blood Lancet Sales Quantity Market Share by Manufacturer in 2025
Figure 22. Global Soft-Contact Blood Lancet Revenue Market Share by Manufacturer in 2025
Figure 23. Producer Shipments of Soft-Contact Blood Lancet by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 24. Top 3 Soft-Contact Blood Lancet Manufacturer (Revenue) Market Share in 2025
Figure 25. Top 6 Soft-Contact Blood Lancet Manufacturer (Revenue) Market Share in 2025
Figure 26. Global Soft-Contact Blood Lancet Sales Quantity Market Share by Region (2021-2032)
Figure 27. Global Soft-Contact Blood Lancet Consumption Value Market Share by Region (2021-2032)
Figure 28. North America Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 33. Global Soft-Contact Blood Lancet Sales Quantity Market Share by Type (2021-2032)
Figure 34. Global Soft-Contact Blood Lancet Consumption Value Market Share by Type (2021-2032)
Figure 35. Global Soft-Contact Blood Lancet Average Price by Type (2021-2032) & (US$/Unit)
Figure 36. Global Soft-Contact Blood Lancet Sales Quantity Market Share by Application (2021-2032)
Figure 37. Global Soft-Contact Blood Lancet Revenue Market Share by Application (2021-2032)
Figure 38. Global Soft-Contact Blood Lancet Average Price by Application (2021-2032) & (US$/Unit)
Figure 39. North America Soft-Contact Blood Lancet Sales Quantity Market Share by Type (2021-2032)
Figure 40. North America Soft-Contact Blood Lancet Sales Quantity Market Share by Application (2021-2032)
Figure 41. North America Soft-Contact Blood Lancet Sales Quantity Market Share by Country (2021-2032)
Figure 42. North America Soft-Contact Blood Lancet Consumption Value Market Share by Country (2021-2032)
Figure 43. United States Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 44. Canada Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 45. Mexico Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 46. Europe Soft-Contact Blood Lancet Sales Quantity Market Share by Type (2021-2032)
Figure 47. Europe Soft-Contact Blood Lancet Sales Quantity Market Share by Application (2021-2032)
Figure 48. Europe Soft-Contact Blood Lancet Sales Quantity Market Share by Country (2021-2032)
Figure 49. Europe Soft-Contact Blood Lancet Consumption Value Market Share by Country (2021-2032)
Figure 50. Germany Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 51. France Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 52. United Kingdom Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 53. Russia Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 54. Italy Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity Market Share by Type (2021-2032)
Figure 56. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity Market Share by Application (2021-2032)
Figure 57. Asia-Pacific Soft-Contact Blood Lancet Sales Quantity Market Share by Region (2021-2032)
Figure 58. Asia-Pacific Soft-Contact Blood Lancet Consumption Value Market Share by Region (2021-2032)
Figure 59. China Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 62. India Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Soft-Contact Blood Lancet Sales Quantity Market Share by Type (2021-2032)
Figure 66. South America Soft-Contact Blood Lancet Sales Quantity Market Share by Application (2021-2032)
Figure 67. South America Soft-Contact Blood Lancet Sales Quantity Market Share by Country (2021-2032)
Figure 68. South America Soft-Contact Blood Lancet Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Soft-Contact Blood Lancet Sales Quantity Market Share by Country (2021-2032)
Figure 74. Middle East & Africa Soft-Contact Blood Lancet Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 76. Egypt Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 77. Saudi Arabia Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 78. South Africa Soft-Contact Blood Lancet Consumption Value (2021-2032) & (USD Million)
Figure 79. Soft-Contact Blood Lancet Market Drivers
Figure 80. Soft-Contact Blood Lancet Market Restraints
Figure 81. Soft-Contact Blood Lancet Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Soft-Contact Blood Lancet in 2025
Figure 84. Manufacturing Process Analysis of Soft-Contact Blood Lancet
Figure 85. Soft-Contact Blood Lancet Industrial Chain
Figure 86. Sales Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
